Raymond James Financial
TXG icon

Raymond James Financial’s 10x Genomics TXG Stock Holding History

Raymond James Financial’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$307K Buy
+14,471
New +$289K ﹤0.01% 4647
2025
Q4 		– Sell
-13,264
Closed -$155K – 5338
2025
Q3 		$155K Sell
13,264
-10,001
-43% -$130K ﹤0.01% 4678
2025
Q2 		$269K Sell
23,265
-8,230
-26% -$75K ﹤0.01% 4360
2025
Q1 		$275K Buy
31,495
+1,490
+5% +$18.8K ﹤0.01% 4266
2024
Q4 		$431K Buy
+30,005
New +$473K ﹤0.01% 3992

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial's TXG Position: Q1 2026 in Review

Raymond James Financial opened a new position in 10x Genomics (TXG) in Q1 2026: 14,471 shares worth $307K. The stake represents ﹤0.01% of the portfolio and ranks #4647 among its holdings. This is a return to the name: Raymond James Financial previously reported a position in TXG as recently as Q3 2025.

Raymond James Financial first reported a position in TXG in Q4 2024 and has held it in 5 quarters since. The position peaked at $431K in Q4 2024. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Raymond James Financial held 14,471 shares of 10x Genomics worth $307K as of Q1 2026.
  • 10x Genomics was a new Raymond James Financial position in Q1 2026.
  • 10x Genomics made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4647 holding.
  • Raymond James Financial first reported a position in 10x Genomics in Q4 2024 and has held it in 5 quarters since.
  • Raymond James Financial's 10x Genomics position peaked at $431K in Q4 2024.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.